These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10544133)

  • 21. Molecular epidemiology and genetic characterization of equine arteritis virus isolates associated with the 2006-2007 multi-state disease occurrence in the USA.
    Zhang J; Timoney PJ; Shuck KM; Seoul G; Go YY; Lu Z; Powell DG; Meade BJ; Balasuriya UB
    J Gen Virol; 2010 Sep; 91(Pt 9):2286-301. PubMed ID: 20444993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleotide sequence and genetic analysis of the leader region of Canadian, American and European equine arteritis virus isolates.
    Kheyar A; St-Laurent G; Diouri M; Archambault D
    Can J Vet Res; 1998 Jul; 62(3):224-30. PubMed ID: 9684053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine arteritis virus derived from an infectious cDNA clone is attenuated and genetically stable in infected stallions.
    Balasuriya UB; Snijder EJ; van Dinten LC; Heidner HW; Wilson WD; Hedges JF; Hullinger PJ; MacLachlan NJ
    Virology; 1999 Jul; 260(1):201-8. PubMed ID: 10405372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmission of the South African asinine strain of equine arteritis virus (EAV) among horses and between donkeys and horses.
    Paweska JT; Aitchison H; Chirnside ED; Barnard BJ
    Onderstepoort J Vet Res; 1996 Sep; 63(3):189-96. PubMed ID: 8917855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of antibodies to equine arteritis virus by enzyme linked immunosorbant assays utilizing G(L), M and N proteins expressed from recombinant baculoviruses.
    Hedges JF; Balasuriya UB; Ahmad S; Timoney PJ; McCollum WH; Yilma T; MacLachlan NJ
    J Virol Methods; 1998 Dec; 76(1-2):127-37. PubMed ID: 9923747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of M-protein C terminus as substrate antigen for serodetection of equine arteritis virus infection.
    Jeronimo C; Archambault D
    Clin Diagn Lab Immunol; 2002 May; 9(3):698-703. PubMed ID: 11986280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of Recombinant EAV with Tagged Structural Protein Gp3 to Study Artervirus Minor Protein Localization in Infected Cells.
    Matczuk AK; Chodaczek G; Ugorski M
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31404947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein.
    Parkinson JE; Sanderson CM; Smith GL
    Virology; 1995 Dec; 214(1):177-88. PubMed ID: 8525613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino acid substitutions in the structural or nonstructural proteins of a vaccine strain of equine arteritis virus are associated with its attenuation.
    Zhang J; Go YY; MacLachlan NJ; Meade BJ; Timoney PJ; Balasuriya UB
    Virology; 2008 Sep; 378(2):355-62. PubMed ID: 18619638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of equine humoral antibody response to the nonstructural proteins of equine arteritis virus.
    Go YY; Snijder EJ; Timoney PJ; Balasuriya UB
    Clin Vaccine Immunol; 2011 Feb; 18(2):268-79. PubMed ID: 21147938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equine Arteritis Virus Elicits a Mucosal Antibody Response in the Reproductive Tract of Persistently Infected Stallions.
    Carossino M; Wagner B; Loynachan AT; Cook RF; Canisso IF; Chelvarajan L; Edwards CL; Nam B; Timoney JF; Timoney PJ; Balasuriya UBR
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28814389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation and phylogenetic analysis of 22 French isolates of equine arteritis virus.
    Zhang J; Miszczak F; Pronost S; Fortier C; Balasuriya UB; Zientara S; Fortier G; Timoney PJ
    Arch Virol; 2007; 152(11):1977-94. PubMed ID: 17680321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large envelope glycoprotein and nucleocapsid protein of equine arteritis virus (EAV) induce an immune response in Balb/c mice by DNA vaccination; strategy for developing a DNA-vaccine against EAV-infection.
    Tobiasch E; Kehm R; Bahr U; Tidona CA; Jakob NJ; Handermann M; Darai G; Giese M
    Virus Genes; 2001 Mar; 22(2):187-99. PubMed ID: 11324756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant equine arteritis virus as an expression vector.
    de Vries AA; Glaser AL; Raamsman MJ; Rottier PJ
    Virology; 2001 Jun; 284(2):259-76. PubMed ID: 11384225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions.
    Hedges JF; Balasuriya UB; Timoney PJ; McCollum WH; MacLachlan NJ
    J Virol; 1999 May; 73(5):3672-81. PubMed ID: 10196259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of different molecular methods for assessment of equine arteritis virus (EAV) infection: a novel one-step MGB real-time RT-PCR assay, PCR-ELISA and classical RT-PCR for detection of highly diverse sequences of Slovenian EAV variants.
    Mankoc S; Hostnik P; Grom J; Toplak I; Klobucar I; Kosec M; Barlic-Maganja D
    J Virol Methods; 2007 Dec; 146(1-2):341-54. PubMed ID: 17854913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equine viral arteritis. Current status in Finland.
    Huovilainen A; Ek-Kommonen C
    Adv Exp Med Biol; 1998; 440():649-53. PubMed ID: 9782341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of antibodies to equine arteritis virus by a monoclonal antibody-based blocking ELISA.
    Cho HJ; Entz SC; Deregt D; Jordan LT; Timoney PJ; McCollum WH
    Can J Vet Res; 2000 Jan; 64(1):38-43. PubMed ID: 10680655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.
    Castillo-Olivares J; Wieringa R; Bakonyi T; de Vries AA; Davis-Poynter NJ; Rottier PJ
    J Virol; 2003 Aug; 77(15):8470-80. PubMed ID: 12857916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allelic Variation in CXCL16 Determines CD3+ T Lymphocyte Susceptibility to Equine Arteritis Virus Infection and Establishment of Long-Term Carrier State in the Stallion.
    Sarkar S; Bailey E; Go YY; Cook RF; Kalbfleisch T; Eberth J; Chelvarajan RL; Shuck KM; Artiushin S; Timoney PJ; Balasuriya UB
    PLoS Genet; 2016 Dec; 12(12):e1006467. PubMed ID: 27930647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.